Comparison of Two Stapled Antimesenteric Anastomosis for CD: a Randomized Control Trial Study
Stapled Antimesenteric Functional End-to-end Anastomosis (Kono-S) Versus Stapled Antimesenteric Isoperistaltic Side-to-side Anastomosis for the Postoperative Recurrence of Crohn's Disease: a Randomized Control Trial Study
Jinling Hospital, China
236 participants
Dec 8, 2022
INTERVENTIONAL
Conditions
Summary
The postoperative recurrence of Crohn's diseases (CD) remains high. Stapled anti-mesenteric functional end-to-end anastomosis was safe for CD patients. Its impact on the postoperative recurrence of CD was unknown. Whether it is superior than the conventional anastomosis (stapled antimesenteric isoperistaltic side-to-side anastomosis) needs explored. The trial aims to compare the different impacts of the two antimesenteric anastomosis configurations on the anastomotic recurrence following bowel resection.
Eligibility
Inclusion Criteria3
- patients with Crohn's disease needing bowel resection and anastomosis;
- ileocolic anastomosis；
- written consent acquired
Exclusion Criteria3
- patients underwent enterostomy;
- small bowel anastomosis;
- anticipating other trial.
Interventions
patients in this arm will receive stapled Kono-S anastomosis after bowel resection
patients in this arm will receive stapled antimesenteric isoperistaltic side-to-side anastomosis after bowel resection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05658081